Cellebrite (CLBT) Director Utsumi Receives 15,190 RSUs

What Happened
Utsumi Ryusuke, a director of Cellebrite DI Ltd. (CLBT), received an award of 15,190 restricted share units (RSUs) on September 17, 2026. The filing reports the RSUs at $0.00 (award/grant), and each RSU represents a contingent right to one ordinary share upon settlement. The award is scheduled to vest on September 17, 2027.

Key Details

• Transaction date: 2026-09-17; Transaction type: Award/Grant (code A). Reported price: $0.00.
• Award size: 15,190 RSUs; each RSU equals one ordinary share upon settlement per footnote.
• Vesting: RSUs vest on 2027-09-17 (per footnote).
• Shares owned after transaction: not specified in the Form 4 filing.
• Filing date: 2026-09-29 — this is more than two business days after the transaction, so the Form 4 appears to have been filed late.

Context
RSUs are a form of equity compensation that convert into shares only if/when they vest and are settled; they are not an immediate cash purchase or sale. Awards like this typically reflect compensation or retention incentives rather than an active market buy/sell decision by the insider.